Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 10 Infertility, Female 2 Hyperandrogenism 2 Thrombocytopenia 1 Rectal Neoplasms 1 Pre-Eclampsia 1 Papillomavirus Infections 1 Papilloma 1 Neutropenia 1 Menstruation Disturbances 1 Lung Neoplasms 1 Insulin Resistance 1 Inflammation 1 Infertility 1 Hirsutism 1 Diabetes, Gestational 1 Cytopenia 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Atypical Squamous Cells of the Cervix 1 Anovulation 1 Anemia 1 Adenocarcinoma of Lung 1

Interventions

Metformin 12 Exercise 6 Inositol 4 High-Intensity Interval Training 3 Ethinyl Estradiol 3 Water 2 Preoperative Exercise 2 Insulin 2 Cyproterone Acetate 2 Acupuncture Therapy 2 ziprasidone 1 exendin (9-39) 1 drospirenone and ethinyl estradiol combination 1 drospirenone 1 adrenosterone 1 Telemedicine 1 Tablets 1 Sugars 1 Standard of Care 1 Resistance Training 1 Pioglitazone 1 Phlebotomy 1 Olanzapine 1 Magnesium Oxide 1 Magnesium 1 Ketones 1 Human Growth Hormone 1 Health Planning Guidelines 1 Growth Hormone 1 Folic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Insulin Resistance × Folic Acid × Clear all

NCT02302326 2020-02-26

PI12/1984

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

Phase NA Completed

Inflammation, Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡